Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
We performed silencing and overexpression studies of flavin containing monooxygenase (FMO) 3 in hyperlipidemic mouse models to examine its effects on trimethylamine N-oxide (TMAO) levels and atherosclerosis. Knockdown of hepatic FMO3 in LDL receptor knockout mice using an antisense oligonucleotide resulted in decreased circulating TMAO levels and atherosclerosis. Surprisingly, we also observed significant decreases in hepatic lipids and in levels of plasma lipids, ketone bodies, glucose, and insulin. FMO3 overexpression in transgenic mice, on the other hand, increased hepatic and plasma lipids. Global gene expression analyses suggested that these effects of FMO3 on lipogenesis and gluconeogenesis may be mediated through the PPARα and Kruppel-like factor 15 pathways. In vivo and in vitro results were consistent with the concept that the effects were mediated directly by FMO3 rather than trimethylamine/TMAO; in particular, overexpression of FMO3 in the human hepatoma cell line, Hep3B, resulted in significantly increased glucose secretion and lipogenesis. Our results indicate a major role for FMO3 in modulating glucose and lipid homeostasis in vivo, and they suggest that pharmacologic inhibition of FMO3 to reduce TMAO levels would be confounded by metabolic interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, there could be several problems with this approach as an accumulation of TMA leads to trimethylaminuria, which is characterized by fishy odor (similar to rotten fish) and induce inflammation [18,75,99].”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [99]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“important regulators in host lipid and sterol metabolism, as well as atherosclerosis development”
From Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis (2015) · cites this paper as Shih et al., 2015
In the citing paper
“FMO3 inhibition is also accompanied by several untoward side effects, including hepatic inflammation”
From Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis (2015) · cites this paper as Shih et al., 2015
In the citing paper
“host hepatic FMO3, the primary FMO responsible for TMAO production”
From Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis (2015) · cites this paper as Shih et al., 2015
In the citing paper
“suppression of the host enzyme, FMO3, through antisense oligonucleotide-based approach, results in reduction of both circulating TMAO levels and diet-enhanced atherosclerosis in animal models”
From Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis (2015) · cites this paper as Shih et al., 2015
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Self-citationInsulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Self-citationIntestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Self-citationRepa, J. J., Liang, G., Ou, J., Bashmakov, Y., Lobaccaro, J.-M. A., Shimomura, I., Shan, B., Brown, M. S., Goldstein, J. L., & Mangelsdorf, D. J. (2000) · Genes & Development · doi:10.1101/gad.844900 · Cited by 1,692
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth
Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y.-L., & Schulze, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.007 · Cited by 1,413
Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089
Bennett, B. J., Vallim, T. Q. D. A., Wang, Z., Shih, D. M., Meng, Y., Gregory, J., Allayee, H., Lee, R., Graham, M., Crooke, R., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.011 · Cited by 1,070
Self-citationLi, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733
Cited by
Items 201–300 of 342
Relationship between serum trimethylamine N-oxide and exposure to dioxin-like pollutants
Petriello, M. C., Charnigo, R. J., Sunkara, M., Soman, S., Pavúk, M., Birnbaum, L. S., Morris, A. J., & Hennig, B. (2018) · Environmental Research · doi:10.1016/j.envres.2018.01.007 · Cited by 18
“For example, in mice FMO3 regulates cholesterol balance and glucose/ insulin signaling in mice (Miao et al., 2015; Schugar and Brown, 2015; Shih et al., 2015; Warrier et al., 2015).”
Ha, J., Kwon, Y., & Park, S. S. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05566-9 · Cited by 19
Emerging roles of xenobiotic detoxification enzymes in metabolic diseases
Petriello, M. C., Hoffman, J. B., Morris, A. J., & Hennig, B. (2016) · Reviews on Environmental Health · doi:10.1515/reveh-2016-0050 · Cited by 19
“showed that a decrease in FMO3 lowered circulating TMAO as well as reduced plasma and liver levels of glucose and lipids in a mouse model highly susceptible to atherosclerosis (21).”
BackgroundA benzoxazole derivative as an inhibitor of anaerobic choline metabolism by human gut microbiota
Gabr, M. T., Machalz, D., Pach, S., & Wolber, G. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00218f · Cited by 15
Osborn, L. J., Orabi, D., Goudarzi, M., Sangwan, N., Banerjee, R., Brown, A. L., Kadam, A., Gromovsky, A. D., Linga, P., Cresci, G., et al. (2021) · Immunometabolism · doi:10.20900/immunometab20210029 · Cited by 15
“This is yet another example whereby the expression of Fmo3 is altered in mouse models of progressive cardiometabolic disease [73–76].”
Self-citationLi, Z., Hui, J., Li, S., Cao, T., Zhang, J., Mao, X., Wang, F., Wang, F., He, P., You, Y.-P., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15249 · Cited by 19
“In contrast, overexpression of FMO3 in - creased plasma TMAO, glucose and insulin levels [ 39 ].”
BackgroundCatucci, G., Polignano, I. L., Cusumano, D., Medana, C., Gilardi, G., & Sadeghi, S. J. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.01.024 · Cited by 14
Gao, X., Jiang, C., Xu, J., Yanagita, T., Xue, C., & Wang, Y. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1206813 · Cited by 15
Cheng, J. Y., Cheng, M., Sinha, S. K., Cely, I., Charugundla, S., Han, M., Zhang, G., Zhou, Z., Gladkikh, S., Ahn, I. S., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323047 · Cited by 18
Self-citationGabr, M. T., & Świderek, K. (2020) · ChemMedChem · doi:10.1002/cmdc.202000571 · Cited by 15
Flavin-Containing Monooxygenase 3 Reduces Endoplasmic Reticulum Stress in Lipid-Treated Hepatocytes
Liao, B. M., McManus, S. A., Hughes, W. E., & Schmitz‐Peiffer, C. (2016) · Molecular Endocrinology · doi:10.1210/me.2015-1217 · Cited by 15
Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases
Usman, I., Anwar, A., Shukla, S., & Pathak, P. (2024) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/011871529x310857240607103028 · Cited by 17
Hana, C. A., Tran, L. V., Mölzer, C., Müllner, E., Hörmann-Wallner, M., Franzke, B., Tosevska, A., Zöhrer, P. A., Doberer, D., Marculescu, R., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154913 · Cited by 14
Yu, N., Gu, N., Wang, Y., Zhou, B., Lu, D., Li, J., Ma, X., Zhang, J., & Guo, X. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s339698 · Cited by 13
Trimethylamine N-Oxide as a Potential Risk Factor for Non-communicable Diseases: A Systematic Review
Tavassol, Z. H., Ejtahed, H., Larijani, B. A., & Hasani‐Ranjbar, S. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666221103120410 · Cited by 12
Xu, C., Zhang, M., Zhang, S., Wang, P., Lai, C., Meng, D., Chen, Z., Yi, X., & Gao, X. (2024) · Journal of Chromatography B · doi:10.1016/j.jchromb.2024.124210 · Cited by 12
Lama, S., Monda, V., Rizzo, M. R., Dacrema, M., Maisto, M., Annunziata, G., Tenore, G. C., Novellino, E., & Stiuso, P. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2961406 · Cited by 12
“To gain an insight about the mechanism through which Taurisolo® sustained the cardiomyocyte viability, we have damaged the H9c2 cardiomioblastic cell line with high glucose concentration (44mM) and TMAO, a molecule linked to obesity and energy metabolism [23, 24] (Figure 1).”
BackgroundMoradzad, M., Abdi, M., Esmaeili, F. S., Ghaderi, D., Rahmani, K., Moloudi, M. R., & Vahabzadeh, Z. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07375-4 · Cited by 12
“TMAO has the potential to play more important roles in the development of NAFLD by affecting the expression of key nuclear receptors (LXR, PPARα, and FXR) involved in lipid metabolism [37].”
BackgroundSorokin, A. V., Kotani, K., Bushueva, O. Y., & Polonikov, A. (2015) · Cardiology in the Young · doi:10.1017/s104795111500102x · Cited by 11
“In addition, flavin-containing monooxygenase 3 exhibits the highest specific activity in oxidising trimethylamine to trimethylamine-N-oxide.(18) In a population study, trimethylamine-N-oxide levels were found to be associated with atherosclerosis.”
The fragility of liver glycogen from humans with type 2 diabetes: A pilot study
Wang, Z., Min, X., Hu, Z., Sullivan, M. A., Tang, Y., Wang, L., Gilbert, R. G., Chen, S., & Deng, B. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.08.212 · Cited by 11
Self-citationThe origin of trimethylamine- N-oxide (TMAO) and its role in development of atherosclerosis
He, Z., & Chen, Z. (2018) · Journal of Food Bioactives · doi:10.31665/jfb.2018.2138 · Cited by 14
“Apart from its critical role in TMAO production, FMO3 was shown to be involved in the modulation of glucose and lipid homeostasis, hepatic cholesterol and triacylglycerol metabolism, and development of obesity (Shih et al. 2015; Warrier et al. 2015; Schugar et al. 2017).”
BackgroundFMO3 deficiency of duck leads to decreased lipid deposition and increased antibacterial activity
Li, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-022-00777-1 · Cited by 10
“Antisense oligonucleotide (ASO)-mediated FMO3 knockdown decreased TMAO levels and retarded AS development in mice, proving the role of this pathway in CVD [73, 75, 76].”
BackgroundInfluentialIbrahim, Z., Khan, N. A., Siddiqui, R., Qaisar, R., Marzook, H., Soares, N. C., & Elmoselhi, A. B. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00836-6 · Cited by 13
Qin, Z., Wu, W., Yang, X., Wang, X., Ding, A., Huang, Y., Tang, J., Jiang, S., Zhang, P., Qian, C., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1592524 · Cited by 15
Wang, C., Duan, X., Li, X., Yang, J., Xue, C., Yanagita, T., Zhang, T., & Wang, Y. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250054 · Cited by 9
Enzymatically Produced Trimethylamine N-Oxide: Conserving It or Eliminating It
Catucci, G., Querio, G., Sadeghi, S. J., Gilardi, G., & Levi, R. C. (2019) · Catalysts · doi:10.3390/catal9121028 · Cited by 11
Neurobiological Basis of Aversion-Resistant Ethanol Seeking in C. elegans
Jee, C., Batsaikhan, E., & Salim, C. (2022) · Metabolites · doi:10.3390/metabo13010062 · Cited by 11
“FMO5/FMO3, the mammalian orthologue of FMO-2, are the major forms of FMOs in livers of mammals [61,62] and have been known to play important roles in regulation of cholesterol and fat metabolism [49,63], in particular reorganizing cholesterol balance and signaling to lipid transporters such as ATP-binding cassette (AB…”
BackgroundZhang, C., He, J., Huo, Y., Liu, L., Xie, Y., Meng, Y., Wei, G., Deng, L., Jiang, Y., & Feng, J. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01159-9 · Cited by 11
“Furthermore, aspirin [63], TMA inhibitors [70], FMO3 inhibitors [71] intestinal immune modulators [72], etc., have evidence showing they can effectively reduce plasma TMAO levels.”
Self-citationLi, T., Sun, Q., Feng, L., Yan, D., Wang, B., Li, M., Xiong, X., Ma, D., & Gao, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276598 · Cited by 11
Peptidomimetic‐based approach toward inhibitors of microbial trimethylamine lyases
Gabr, M. T., Deganutti, G., & Reynolds, C. A. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13775 · Cited by 10
“for discovery of gut microbiota-targeted small molecules (Shih et al., 2015).”
BackgroundDiet-mediated metaorganismal relay biotransformation: health effects and pathways
Li, Y., Cao, H., Wang, X., Guo, L., Ding, X., Zhao, W., & Zhang, F. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2004993 · Cited by 9
García-Fernández, H., Alcala-Diaz, J. F., Quintana‐Navarro, G. M., López-Moreno, J., Luque-Córdoba, D., Narváez, E. R.-D., Larriva, A. P. A.-D., Gutierrez-Mariscal, F. M., Torres-Peña, J. D., Rodríguez-Cano, D., et al. (2024) · The World Journal of Men s Health · doi:10.5534/wjmh.230366 · Cited by 10
“In contrast, the overexpression of FMO3 in transgenic mice affects lipogenesis and gluconeogenesis, thus demonstrating the key role of FMO3 in modulating glucose and lipid homeostasis [21].”
BackgroundBahramirad, Z., Moloudi, M. R., Moradzad, M., Abdolahi, A., & Vahabzadeh, Z. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10754-0 · Cited by 11
“TMAO reduces the 7α-hydroxylase activity, a key and rate-limiting enzyme, to suppress bile acid production (Shih et al. 2015).”
Gawryś-Kopczyńska, M., Szudzik, M., Samborowska, E., Konop, M., Chabowski, D. S., Onyszkiewicz, M., & Ufnal, M. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1340166 · Cited by 8
Zou, L., Shi, Q., Li, Y., Yuan, Z., Peng, L. J., Lu, J., Zhu, H., & Ma, J. (2023) · Discovery Medicine · doi:10.24976/discov.med.202335177.60 · Cited by 8
Gut microbiota: A new protagonist in the risk of cardiovascular disease?
García‐Ríos, A., García, A. C., Pérez‐Jiménez, F., & Pérez‐Martínez, P. (2019) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2018.11.004 · Cited by 8
James, K. L., Gertz, E., Kirschke, C. P., Allayee, H., Huang, L., Kable, M. E., Newman, J. W. I., Stephensen, C. B., & Bennett, B. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032074 · Cited by 8
“However, in LDLR-/- mice treated with an antisense nucleotide to knockdown FMO3, TMAO levels were reduced but TNF-α expression remained significantly higher than that in the control [38].”
BackgroundSelf-citationDean, Y. E., Rouzan, S. S., Pintado, J. J. L., Talat, N. E., Mohamed, A. R. H., Verma, S., Kamdi, Z. A., Gir, D., Helmy, A., Helmy, Z., et al. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001426 · Cited by 8
Practical Aspects of Flavin-Containing Monooxygenase-Mediated Metabolism
Cashman, J. R. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00316 · Cited by 8
Fermented Ginseng Contains an Agonist of Peroxisome Proliferator Activated Receptors α and γ
Igami, K., Shimojo, Y., Ito, H., Miyazaki, T., Nakano, F., & Kashiwada, Y. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3673 · Cited by 6
Dietary Fiber and Hyperlipidemia and Cardiovascular Disease
Tovar, A. R., Guevara‐Cruz, M., Serralde-Zúñiga, A. E., & Torres, N. (2020) · Food engineering series · doi:10.1007/978-3-030-38654-2_10 · Cited by 7
Monoamine Oxidases and Flavin-Containing Monooxygenases
Cashman, J. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64091-6 · Cited by 6
Flavin-containing monooxygenase
Choe, J., Moon, H., & Shin, S. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb5z8t/pdb · Cited by 6
Battillo, D. J., & Malin, S. K. (2025) · Experimental Physiology · doi:10.1113/ep092550 · Cited by 5
TMAO Accumulation Induced by Hyperglycemia Triggers Endoplasmic Reticulum Stress in the Mouse Liver
Gao, Q., Li, T., AL‐Ansi, W., Fan, M., Qian, H., Li, Y., & Wang, L. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70278 · Cited by 5
Crosstalk between the m6A modification and the gut microbiota in lipid metabolism
Chen, H., Ren, Y., Yu, J., Ren, J., Zeng, Y., Wu, Y., Zhang, Q., & Xiao, X. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128356 · Cited by 6
Inhaled microcystin-LR may induce acute liver failure through hepatic congestion
Jung, W., Yang, M., Jo, S.-H., Lee, J. A., Kwon, N. C., Choi, S., Choi, H., Choi, C. W., Lee, M., Kim, J., et al. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.119361 · Cited by 5
Dean, Y. E., Shebl, M. A., Doma, M., Elmezayen, R. W., Pintado, J. J. L., Rouzan, S. S., Hassan, N. A. I. F., Yaqout, Y. E., Tokunaga, A., Anozie, C., et al. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002516 · Cited by 5
Dadi, I. S., Saravani, R., Khalili, T., Sargazi, S., Majidpour, M., Sarhadi, M., Mirinejad, S., Shahraki, S., & Alidadi, A. (2022) · Reports of Biochemistry and Molecular Biology · doi:10.52547/rbmb.11.3.430 · Cited by 5
Agarwal, M., Roth, K., Yang, Z., Sharma, R., Maddipati, K. R., Westrick, J. A., & Petriello, M. C. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118492 · Cited by 6
Kim, M., Huda, M. N., O’Connor, A., Albright, J., Durbin-Johnson, B. P., & Bennett, B. J. (2021) · Physiological Genomics · doi:10.1152/physiolgenomics.00140.2020 · Cited by 7
Self-citationRelationship between Red Meat Metabolite Trimethylamine N-oxide and Cardiovascular Disease
Yousuf, A., McVey, D. G., & Ye, S. (2022) · Heart and Mind · doi:10.4103/hm.hm_8_21 · Cited by 5
Heianza, Y., Zhou, T., He, H., DiDonato, J. A., Bray, G. A., Sacks, F. M., & Qi, L. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00939-7 · Cited by 5
Senthong, V., Kiatchoosakun, S., Wongvipaporn, C., Phetcharaburanin, J., Sritara, P., Phrommintikul, A., CORE Investigators, Sritara, P., Yamwong, S., Srimahachota, S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-71479-z · Cited by 6
“In contrast, FMO3 knockdown mice showed decreased circulating TMAO levels and attenuated atherosclerotic plaque formation 24 .”
BackgroundMicrobiota intestinal: ¿un nuevo protagonista en el riesgo de enfermedad cardiovascular?
García‐Ríos, A., García, A. C., Pérez‐Jiménez, F., & Pérez‐Martínez, P. (2019) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2018.11.003 · Cited by 6
Li, B., Yang, S., Ye, J.-R., Chu, S., Chen, N., & An, Z. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136222 · Cited by 4
Putro, P. S., Indarto, D., Purwanto, B., Soewondo, W., Kusumaningrum, S., & Nguzum, K. Y. (2023) · Pharmacognosy Journal · doi:10.5530/pj.2022.14.166 · Cited by 4
Unaccounted risk of cardiovascular disease: the role of the microbiome in lipid metabolism
Joris, B. R., & Gloor, G. B. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000582 · Cited by 4
von Eckardstein, A. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13086 · Cited by 4
PCSK9 and APOA4 : The Dynamic Duo in TMAO-induced Cholesterol Metabolism and Cholelithiasis
Shi, C., Yu, J., Meng, Z., Lu, D.-Y., Ding, H., Sun, H., Shi, G., Xue, D., & Meng, X. (2025) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2024.00403 · Cited by 9
“32 FMO3 transcription also mediates the activation of the TMA/Fmo3/TMAO pathway, upregulating ABCG5/8, thereby promoting the formation of cholesterol gallstones.”
Zhang, N., Wang, Y., Luo, G., & Gao, X. (2026) · Nutrients · doi:10.3390/nu18111659 · Cited by 4
“Unlike the direct inhibition of host hepatic FMO3, which may lead to TMA accumulation (e.g., trimethylaminuria) or hepatic injury [26,27], targeting CutC specifically blocks intestinal TMA production without interfering with the host’s endogenous choline metabolism.”
Song, J., Shi, X., Li, X., Liang, Q., Zeng, L., Li, G., Yan, Y., Xu, G., & Zheng, J. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.868602 · Cited by 4
“They argued that pharmacological inhibition of FMO3 to reduce TMAO levels would be confounded by metabolic interactions (11, 12).”
BackgroundFlavin-containing Monooxygenases in the Brain and their Involvement in Neurodegeneration and Aging
Li, B., & An, Z. (2023) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2022.00067 · Cited by 4
Insight into increased risk of portal vein thrombosis in nonalcoholic fatty liver disease
Gong, H., Zhong, H., Xu, H., Liu, X.-C., Liang-ping, L., & Zhang, D. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.06.011 · Cited by 3
Takenoya, F., Shibato, J., Yamashita, M., Kimura, A., Hirako, S., Chiba, Y., Nonaka, N., Shioda, S., & Rakwal, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115825 · Cited by 3
Huang, M., Duan, S., Zhang, Q., Guo, L., Qin, Z., & Yang, J. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106538 · Cited by 3
Dysbiosis and Regulation of Gut Microbiota in Type 2 Diabetes Mellitus
Minakshi, Kumari, H., Prakash, S., & Kumar, A. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010318580240910061534 · Cited by 5
Chilloux, J., Brial, F., Everard, A., Smyth, D. R., Andrikopoulos, P., Zhang, L., Plovier, H., Myridakis, A., Hoyles, L., Moreno‐Navarrete, J. M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/277434 · Cited by 3
Chen, B., Chen, M., Pan, X., Bai, M., Sun, D., Jiang, H., Lin, N., & Ma, Z. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100133 · Cited by 4
Kurhaluk, N., Mazur, Z., Kołodziejska, R., & TKACZENKO, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083511 · Cited by 6
Samanthapudi, V. S. K., Mendoza, K. C. O., Puvvala, S. P., Kamma, S., & Kotla, S. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104703 · Cited by 2
The Novel Dimensions of Cardio-Metabolic Health: Gut Microbiota, Dysbiosis and its Fallouts
Vinod, N. (2019) · Significances of Bioengineering & Biosciences · doi:10.31031/sbb.2019.03.000565 · Cited by 2
The Novel Dimensions of Cardio-Metabolic Health: Gut Microbiota, Dysbiosis and its Fallouts
Nikhra, V. (2019) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2019.11.555805 · Cited by 2
“In mice studies, the hepatic knockdown of FMO3 by antisense oligonucleotide decreased circulating TMAO levels and attenuated atherosclerosis through activating macrophage reverse cholesterol transport [54].”
BackgroundCommensal Microbes and Their Metabolites: Influence on Host Pathways in Health and Cancer
Méndez, R., Banerjee, S., & Banerjee, S. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_10 · Cited by 1
Yang, Z., Stemmer, P. M., & Petriello, M. C. (2022) · Toxics · doi:10.3390/toxics10020060 · Cited by 4
“discovered that ASO-mediated knockdown of FMO3 significantly reduced plasma lipid level, including triglyceride, VLDL, and LDL [63].”
BackgroundInfluentialZhang, W., Gao, Y., Song, S., & Gao, F. (2022) · Soft Computing · doi:10.1007/s00500-022-07368-2 · Cited by 3
Walter, J. H., Wevers, R. A., & Mayatepek, E. (2016) · Springer eBooks · doi:10.1007/978-3-662-49771-5_30 · Cited by 2
Yam, P., VerHague, M., Albright, J., Gertz, E., de Villena, F. P., & Bennett, B. J. (2022) · Genes & Nutrition · doi:10.1186/s12263-022-00714-x · Cited by 2
“Intriguingly, studies in the mouse have suggested additional roles for FMO3 in health and disease, such as modulating cholesterol metabolism [96], glucose, and lipid homeostasis [78], and as a target for downregulation by insulin [58].”
BackgroundSelf-citationKey roles of Drosophila flavin-containing monooxygenases in lipid metabolism and longevity
Wei, Q., Xue, Y., Fan, J., & Su, J. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146851 · Cited by 1
Dobhal, S., Kaushik, M., Manhas, P. L., Kumar, A., Naithani, P., Gupta, P., Kaushik, H., Naithani, M., Omar, B. J., Kothari, A., et al. (2025) · Indian Journal of Microbiology · doi:10.1007/s12088-025-01516-6 · Cited by 1
“On the other hand, lowering levels of liver enzyme or knocking out the Flavin-containing monooxygenase 3 (FMO3) may reduce TMAO levels and slow down atherosclerosis in animal models [99].”
Alvarado, S. J., Enciso, M. F. F., Amedei, A., & Aguirre‐García, M. M. (2026) · World Journal of Cardiology · doi:10.4330/wjc.v18.i3.116780 · Cited by 1
The Gut Microbiota-Metabolite-Host Axis in Cardiometabolic Diseases: Bridging Bench to Bedside
Chen, L., & Yang, D. (2026) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-026-07875-6 · Cited by 1
The gut–brain axis and trimethylamine N-oxide: an emergent biomarker in neurological diseases
Arangia, A., Paola, R. D., Cuzzocrea, S., Siracusa, R., D’Amico, R., & Impellizzeri, D. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.05.005 · Cited by 1
Wang, G., Song, G., Wang, L., Gao, F., Guo, N., Zhang, Y., Zhao, N., & Yin, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5149 · Cited by 2
“The origin of atherosclerosis is well known, mainly due to the metabolic abnormalities of glucose and lipid, which is similar to the pathological phenomenon caused by MS (17,18).”
Astaf’ev, A. A. (2017) · EngagedScholarship @ Cleveland State University (Cleveland State University) · Cited by 2
Gut microbiota interaction in host lipid metabolism
Golonka, R. M., Abokor, A. A., Ntambi, J. M., & Vijay–Kumar, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00016-6 · Cited by 3
Gut microbiota and lipid metabolism and metabolic syndrome
Duttaroy, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822405-2.00029-3 · Cited by 1
Skalniak, A., Trofimiuk–Müldner, M., Jabrocka‐Hybel, A., Totoń‐Żurańska, J., Wołkow, P. P., & Hubalewska–Dydejczyk, A. (2023) · Endokrynologia Polska · doi:10.5603/ep.a2023.0009 · Cited by 1
Association between gut microbiota and thyroid dysfunction
Алексеевич, Т. А., Александровна, М. О., Олеговна, Щ. А., Martirosian, N. S., Валерьевна, Г. Е., Кузина, И. А., Эдуардовна, Т. М., Valeeva, F. V., & Petunina, N. A. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-073 · Cited by 1
Shokati, S., Sargazi, S., Majidpour, M., Mirinejad, S., Ghale-Noie, Z. N., Shahraki, M., Sargazi, S., & Piri, M. (2025) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-024-01295-9 · Cited by 1
“A gradual reduction of plasma TMAO can reduce plasma glucose and insulin lev - els by inhibiting FMO3 [ 52 ].”
Functionalized cardiovascular stents: Cardiovascular stents incorporated with stem cells
Oh, B., & Lee, C. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100496-8.00014-7 · Cited by 1
Gut bacterial metabolite TMA induces hepatic metabolic stress and inflammation via mediation of A20
Kaluzny, S., & Su, Q. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121002287 · Cited by 1
Xu, Z. W. (2017) · doi:10.23860/thesis-xu-zhen-2017 · Cited by 2
“Mice deficient in Fmo3 or Fmo5 showed lean phenotypes with favorable lipid and sugar profiles, and transgenic expression of Fmo3 had the opposite effect (Shephard and Phillips, 2010; Veeravalli et al., 2014; Shih et al., 2015; Schugar et al., 2017; Scott et al., 2017).”
BackgroundKim, S.-J., Bale, S., Wan, Q., Gudjonsson, J. E., Hazen, S. L., Harms, P. W., Tsou, P., Khanna, D., Tsoi, L. C., Gupta, N., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3912949 · Cited by 1
Self-citationThe role of hepatic FoxO1 in insulin resistance
Ling, A. V. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Smallwood, T. (2015) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/v8q7-2m69
Effects of Egg Intake on Choline Metabolism and HDL Functionality in a Healthy Population
Lemos, B. S. (2019) · OpenCommons at University of Connecticut (University of Connecticut) · Cited by 1
Wilson, S. M. (2018) · Montana State University ScholarWorks (Montana State University)
Role of Hepatic PEMT and Dietary Choline in the Development of Atherosclerosis
Zia, Y. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3736mj2x
Brandão, C. F. C. E. C. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-10042019-092726
Metadata
- Authors
- Shih, D. M., Wang, Z., Lee, R., Meng, Y., Che, N., Charugundla, S., Qi, H., Wu, J., Pan, C., Brown, J. M., Vallim, T., Bennett, B. J., Graham, M., Hazen, S. L., & Lusis, A. J.
- Affiliations
- University of California, Los Angeles (US)
- Cleveland Clinic (US)
- Ionis Pharmaceuticals (United States) (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Lusis, Aldons J.
- ORCID
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 56
- Issue
- 1
- Pages
- 22-37
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC4274068
- OpenAlex
- W2163604084
- Cited by
- 335
- References
- 46
- Citations by year
- 2026: 17 · 2025: 19 · 2024: 18 · 2023: 20 · 2022: 43 · 2021: 36 · 2020: 44 · 2019: 33 · 2018: 28 · 2017: 28 · 2016: 33 · 2015: 16
- FWCI
- 29.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2088 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- UNC Libraries
- Funders
- National Institutes of Health (HL‐28481, HL30568, HL113452)
- National Heart, Lung, and Blood Institute (HL3 0568, HL28481, P01HL030568, HL113452, P20HL113452, P01HL028481)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- FMO3, trimethylamine N-oxide, atherosclerosis, glucose metabolism, lipid metabolism, hepatic lipogenesis, gluconeogenesis, PPARα, KLF15, hyperlipidemia, LDL receptor knockout mice, hepatic lipid accumulation, insulin, ketone bodies
- MeSH terms
- Animals, Bile Acids and Salts, DNA-Binding Proteins, Feces, Female, Glucose, Homeostasis, Humans, Insulin, Intestinal Mucosa, Lipoproteins, Liver, Methylamines, Oxygenases, Receptors, LDL, Transcription Factors, Gene Expression Regulation, Enzymologic, Cell Line, Tumor, PPAR alpha, Lipogenesis, Atherosclerosis, Lipid Metabolism, Mice, Kruppel-Like Transcription Factors, Gene Knockdown Techniques, Gene Knockout Techniques, Diet, Western
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.